189 related articles for article (PubMed ID: 7686030)
1. Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin-3.
Kobayashi S; Teramura M; Hoshino S; Motoji T; Oshimi K; Mizoguchi H
Br J Haematol; 1993 Apr; 83(4):539-44. PubMed ID: 7686030
[TBL] [Abstract][Full Text] [Related]
2. Spontaneous megakaryocyte colony formation in myeloproliferative disorders is not neutralizable by antibodies against IL3, IL6 and GM-CSF.
Li Y; Hetet G; Maurer AM; Chait Y; Dhermy D; Briere J
Br J Haematol; 1994 Jul; 87(3):471-6. PubMed ID: 7993786
[TBL] [Abstract][Full Text] [Related]
3. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
[TBL] [Abstract][Full Text] [Related]
4. Clonality assays and megakaryocyte culture techniques in essential thrombocythemia.
Yan L; Elkassar N; Gardin C; Briere J
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():31-40. PubMed ID: 8951770
[TBL] [Abstract][Full Text] [Related]
5. Megakaryocytopoiesis in polycythemia vera: characterization by megakaryocytic progenitors (CFU-Meg) in vitro and quantitation of marrow megakaryocytes.
Kimura H; Ohkoshi T; Matsuda S; Uchida T; Kariyone S
Acta Haematol; 1988; 79(1):1-6. PubMed ID: 3124455
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of in vitro growth pattern of megakaryocyte progenitors (CFU-M) in myeloproliferative disorders.
Hamaguchi H; Takano N; Sakamaki H; Enokihara H; Saito K; Furusawa S; Shishido H
Eur J Haematol; 1988 Aug; 41(2):163-9. PubMed ID: 3410010
[TBL] [Abstract][Full Text] [Related]
7. Presence and characteristics of circulating megakaryocyte progenitor cells in human fetal blood.
Zauli G; Valvassori L; Capitani S
Blood; 1993 Jan; 81(2):385-90. PubMed ID: 7678515
[TBL] [Abstract][Full Text] [Related]
8. Hypersensitivity of megakaryocyte progenitors to thrombopoietin in essential thrombocythemia.
Kawasaki H; Nakano T; Kohdera U; Kobayashi Y
Am J Hematol; 2001 Nov; 68(3):194-7. PubMed ID: 11754402
[TBL] [Abstract][Full Text] [Related]
9. Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders.
Battegay EJ; Thomssen C; Nissen C; Gudat F; Speck B
Eur J Haematol; 1989 Apr; 42(4):321-6. PubMed ID: 2656291
[TBL] [Abstract][Full Text] [Related]
10. The effect of mast cell growth factor on peripheral blood granulocyte-macrophage colony-forming cells in methylcellulose in myeloproliferative disorders.
Siitonen T; Zheng A; Savolainen ER; Koistinen P
Eur J Haematol; 1995 Oct; 55(4):228-34. PubMed ID: 7589339
[TBL] [Abstract][Full Text] [Related]
11. In vitro studies of megakaryocytopoiesis in thrombocytotic disorders of man.
Gewirtz AM; Bruno E; Elwell J; Hoffman R
Blood; 1983 Feb; 61(2):384-9. PubMed ID: 6821705
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of the primitive megakaryocyte progenitors (BFU-meg) in adult human peripheral blood.
Zauli G; Vitale L; Brunelli MA; Bagnara GP
Exp Hematol; 1992 Aug; 20(7):850-4. PubMed ID: 1378407
[TBL] [Abstract][Full Text] [Related]
13. Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders.
Hibbin JA; Njoku OS; Matutes E; Lewis SM; Goldman JM
Br J Haematol; 1984 Jul; 57(3):495-503. PubMed ID: 6743569
[TBL] [Abstract][Full Text] [Related]
14. Multifactor stimulation of megakaryocytopoiesis: effects of interleukin 6.
Quesenberry PJ; McGrath HE; Williams ME; Robinson BE; Deacon DH; Clark S; Urdal D; McNiece IK
Exp Hematol; 1991 Jan; 19(1):35-41. PubMed ID: 1703492
[TBL] [Abstract][Full Text] [Related]
15. Essential thrombocythemia: impaired regulation of megakaryocyte progenitors.
Zauli G; Catani L; Gugliotta L; Gaggioli L; Vitale L; Belmonte MM; Aglietta M; Bagnara GP
Int J Cell Cloning; 1991 Jan; 9(1):43-56. PubMed ID: 2010654
[TBL] [Abstract][Full Text] [Related]
16. Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group.
Michiels JJ; Juvonen E
Semin Thromb Hemost; 1997; 23(4):339-47. PubMed ID: 9263350
[TBL] [Abstract][Full Text] [Related]
17. Megakaryocyte-related interleukins in reactive thrombocytosis versus autonomous thrombocythemia.
Haznedaroğlu IC; Ertenli I; Ozcebe OI; Kiraz S; Ozdemir O; Sayinalp NM; Dündar SV; Calgüneri M; Kirazli S
Acta Haematol; 1996; 95(2):107-11. PubMed ID: 8638438
[TBL] [Abstract][Full Text] [Related]
18. Increased fibroblast colony stimulating activity (F-CSA) in serum of myeloproliferative disorders.
Han ZC; Briere J; Parent D; Abgrall JF; Sensebe L
J Biol Regul Homeost Agents; 1988; 2(3):119-24. PubMed ID: 3267102
[TBL] [Abstract][Full Text] [Related]
19. Megakaryocyte progenitors derived from bone marrow or G-CSF-mobilized peripheral blood CD34 cells show a distinct phenotype and responsiveness to interleukin-3 (IL-3) and PEG-recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF).
Catani L; Gugliotta L; Campanini E; Mangianti S; Gibellini D; Baravelli S; Vianelli N; Lemoli RM; Tura S
Br J Haematol; 1998 Jan; 100(1):207-18. PubMed ID: 9450813
[TBL] [Abstract][Full Text] [Related]
20. Flow cytometric analysis of megakaryocyte ploidy in chronic myeloproliferative disorders and reactive thrombocytosis.
Jacobsson S; Carneskog J; Ridell B; Wadenvik H; Swolin B; Kutti J
Eur J Haematol; 1996 May; 56(5):287-92. PubMed ID: 8641402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
